Child Development Disorders, Pervasive - Drug therapy
Research News and Information

Sunday, November 22, 2009

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

30 May 2009 OBJECTIVE: The aim of this study was to determine the effectiveness and tolerability of aripiprazole for irritability in pervasive developmental disorder not otherwise specified (PDD-NOS) and Asperger's disorder. METHOD: This is a 14-week, ... Read more...

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

30 May 2009 CONTEXT: Selective serotonin reuptake inhibitors are widely prescribed for children with autism spectrum disorders. OBJECTIVES: To determine the efficacy and safety of citalopram hydrobromide therapy for repetitive behavior in children with autism ... Read more...

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

10 May 2009 Medication use was examined in 286 adolescents and adults with ASD over a 4.5 year period. A total of 70% were taking a psychotropic or non-psychotropic medication at the beginning of the study. Both the number of psychotropic and non-psychotropic ... Read more...

Latest indexed articles for 'Child Development Disorders, Pervasive - Drug therapy'

These are the very latest articles for this heading:

• Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. 30 May 2009
• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. 30 May 2009
• A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. 10 May 2009
• Limited evidence for the effectiveness of p.r.n. Medications among psychiatric inpatients. 29 Apr 2009
• Retrial of selective serotonin reuptake inhibitors in children with pervasive developmental disorders: a retrospective chart review. 30 Mar 2009
• Health care costs and utilization rates for children with pervasive developmental disorders in North Dakota from 1998 to 2004: impact on Medicaid. 30 Jan 2009
• Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness. 30 Dec 2008
• Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. 30 Dec 2008
• [Retrospective analysis of pervasive developmental disorder patients initially diagnosed with attention deficit/hyperactivity disorder] 30 Dec 2008
• Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. 17 Dec 2008
• Should tactile sensation impairment be considered in pharmacotherapy of pervasive developmental disorders? A case report. 29 Nov 2008
• Developing drugs for core social and communication impairment in autism. 29 Sep 2008
• Pharmacotherapy of irritability in pervasive developmental disorders. 29 Sep 2008
• Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. 26 Aug 2008
• Corticosteroid treatment of behaviour, language and motor regression in childhood disintegrative disorder. 12 Jul 2008
• Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder. 30 Jan 2008
• A systematic review of off-label uses of memantine for psychiatric disorders. 15 Jan 2008
• Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. 30 Dec 2007
• Pharmacological treatment options for autism spectrum disorders in children and adolescents. 30 Dec 2007
• Mood and anxiety symptoms in an adolescent with Pervasive Developmental Disorder Not Otherwise Specified and moderate mental retardation. 29 Sep 2007

See a longer list of these articles.

Technical information about 'Child Development Disorders, Pervasive'

Definition: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.

Descriptor UI: D002659

Alternative terms: Child Development Disorders, Pervasive; Pervasive Child Development Disorders; Pervasive Development Disorders; Development Disorder, Pervasive; Development Disorders, Pervasive; Disorder, Pervasive Development; Disorders, Pervasive Development; Pervasive Development Disorder;

Allowable Qualifiers: drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology; blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy;

Tree Number: F03.550.325;

History Note: 81

Technical Notes: "pervasive" is a psychiatric diag: follow text; check also tag CHILD or specific